Cargando…

Development of Novel Galactosylated PLGA Nanoparticles for Hepatocyte Targeting Using Molecular Modelling

Doxorubicin-loaded PLGA nanoparticles conjugated with a new galactose-based ligand for the specific recognition by human hepatoma cellular carcinoma cells (Hep G2) were successfully produced. The new targeting compound was selected using molecular docking combined with quantum chemical calculations...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raposo, Cláudia D., Costa, Rita, Petrova, Krasimira T., Brito, Catarina, Scotti, Marcus T., Cardoso, M. Margarida
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7023654/ https://www.ncbi.nlm.nih.gov/pubmed/31947904 http://dx.doi.org/10.3390/polym12010094

Ejemplares similares

Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity
por: Siu, Frederick YK, et al.
Publicado: (2018)

Preliminary Study on Hepatocyte-Targeted Phosphorus-31 MRS Using ATP-Loaded Galactosylated Chitosan Oligosaccharide Nanoparticles
por: Yu, Ri-Sheng, et al.
Publicado: (2013)

Synthesis of novel tetravalent galactosylated DTPA-DSPE and study on hepatocyte-targeting efficiency in vitro and in vivo
por: Xiao, Yan, et al.
Publicado: (2013)

Galactosylated Albumin Nanoparticles of Simvastatin
por: Ganesh, Kumar, et al.
Publicado: (2015)

Hepatocyte-targeting gene transfer mediated by galactosylated poly(ethylene glycol)-graft-polyethylenimine derivative
por: Wang, Yuqiang, et al.
Publicado: (2013)

Synthesis and biological activity of α-galactosyl ceramide KRN7000 and galactosyl (α1→2) galactosyl ceramide
por: Veerapen, Natacha, et al.
Publicado: (2009)

A Comparison of Hepatocyte Cytotoxic Mechanisms for Docetaxel and PLGA-Docetaxel Nanoparticls
por: Daraei, Bahram, et al.
Publicado: (2017)

Galactosylated Chitosan Oligosaccharide Nanoparticles for Hepatocellular Carcinoma Cell-Targeted Delivery of Adenosine Triphosphate
por: Zhu, Xiu Liang, et al.
Publicado: (2013)

Decreased hepatic function in patients with hepatoma or liver metastasis monitored by a hepatocyte specific galactosylated radioligand.
por: Virgolini, I., et al.
Publicado: (1990)

Ultrasound Exposure Improves the Targeted Therapy Effects of Galactosylated Docetaxel Nanoparticles on Hepatocellular Carcinoma Xenografts
por: Wei, Hongfen, et al.
Publicado: (2013)

Galactosylated hydroxyl‐polyamidoamine dendrimer targets hepatocytes and improves therapeutic outcomes in a severe model of acetaminophen poisoning‐induced liver failure
por: Porterfield, Joshua E., et al.
Publicado: (2023)

Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis
por: Wu, Zi Chao, et al.
Publicado: (2022)

Galactosylated chitosan-functionalized mesoporous silica nanoparticles for efficient colon cancer cell-targeted drug delivery
por: Liu, Wei, et al.
Publicado: (2018)

Evaluation of Intestinal Absorption Mechanism and Pharmacokinetics of Curcumin-Loaded Galactosylated Albumin Nanoparticles
por: Huang, Yike, et al.
Publicado: (2019)

Preparation of PLGA Nanoparticles by Milling Spongelike PLGA Microspheres
por: Lee, Jimin, et al.
Publicado: (2022)

ROS-responsive Galactosylated-nanoparticles with Doxorubicin Entrapment for Triple Negative Breast Cancer Therapy
por: Zhou, Jingyi, et al.
Publicado: (2023)

Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery
por: Liu, Wei, et al.
Publicado: (2018)

Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration
por: Huang, Yike, et al.
Publicado: (2018)

Aptamer-labeled PLGA nanoparticles for targeting cancer cells
por: Aravind, Athulya, et al.
Publicado: (2012)

Cytotoxicity of targeted PLGA nanoparticles: a systematic review
por: Chiu, Hock Ing, et al.
Publicado: (2021)

Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases
por: Dekkers, Gillian, et al.
Publicado: (2018)

Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain
por: Patel, Bhavin K, et al.
Publicado: (2018)

Targeting COPD with PLGA-Based Nanoparticles: Current Status and Prospects
por: Saxena, Juhi, et al.
Publicado: (2022)

Double-Walled Poly-(D,L-lactide-co-glycolide) (PLGA) and Poly(L-lactide) (PLLA) Nanoparticles for the Sustained Release of Doxorubicin
por: Cardoso, M. Margarida, et al.
Publicado: (2021)

Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma
por: Oh, Hea Ry, et al.
Publicado: (2016)

Modifying glycyrrhetinic acid liposomes with liver-targeting ligand of galactosylated derivative: preparation and evaluations
por: Chen, Jing, et al.
Publicado: (2017)

Co-association of methotrexate and SPIONs into anti-CD64 antibody-conjugated PLGA nanoparticles for theranostic application
por: Moura, Catarina Costa, et al.
Publicado: (2014)

Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death
por: Choi, Yongwhan, et al.
Publicado: (2020)

Novel PLGA-based nanoparticles for the oral delivery of insulin
por: Malathi, Sampath, et al.
Publicado: (2015)

Tetracycline-grafted PLGA nanoparticles as bone-targeting drug delivery system
por: Wang, Hua, et al.
Publicado: (2015)

Functionalization of Morin-Loaded PLGA Nanoparticles with Phenylalanine Dipeptide Targeting the Brain
por: Alonso, Mario, et al.
Publicado: (2022)

Galactosylated Prodrugs: A Strategy to Improve the Profile of Nonsteroidal Anti-Inflammatory Drugs
por: Sodano, Federica, et al.
Publicado: (2022)

PLGA-Based Nanoparticles in Cancer Treatment
por: Rezvantalab, Sima, et al.
Publicado: (2018)

PEG–PLGA nanoparticles for encapsulating ciprofloxacin
por: Watcharadulyarat, Natsorn, et al.
Publicado: (2023)

Local Targeted Therapy of Liver Metastasis from Colon Cancer by Galactosylated Liposome Encapsulated with Doxorubicin
por: Zhao, Chen, et al.
Publicado: (2013)

In vitro and in vivo antitumor effects of lupeol-loaded galactosylated liposomes
por: Zhang, Jun, et al.
Publicado: (2021)

Enhanced Immunomodulatory Effect of Intravenous Immunoglobulin by Fc Galactosylation and Nonfucosylation
por: Mimura, Yusuke, et al.
Publicado: (2022)

Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile
por: Rafiei, Pedram, et al.
Publicado: (2017)

Dual Drug Delivery of Sorafenib and Doxorubicin from PLGA and PEG-PLGA Polymeric Nanoparticles
por: Babos, György, et al.
Publicado: (2018)

Sustained in vitro interferon-beta release and in vivo toxicity of PLGA and PEG-PLGA nanoparticles
por: Fodor-Kardos, Andrea, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qtrd1hlioef9rakolv4l8nrbcc